These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 1782363)
1. Chromosomal abnormality t(9;22)(q22;q12) in an extraskeletal myxoid chondrosarcoma characterized by fine needle aspiration cytology, electron microscopy, immunohistochemistry and DNA flow cytometry. Orndal C; Carlén B; Akerman M; Willén H; Mandahl N; Heim S; Rydholm A; Mitelman F Cytopathology; 1991; 2(5):261-70. PubMed ID: 1782363 [TBL] [Abstract][Full Text] [Related]
2. Extraskeletal myxoid chondrosarcoma: multimodal diagnosis and identification of a new cytogenetic subgroup characterized by t(9;17)(q22;q11). Bjerkehagen B; Dietrich C; Reed W; Micci F; Saeter G; Berner A; Nesland JM; Heim S Virchows Arch; 1999 Nov; 435(5):524-30. PubMed ID: 10592057 [TBL] [Abstract][Full Text] [Related]
3. Translocation (9;22)(q22;q12). A recurrent chromosome abnormality in extraskeletal myxoid chondrosarcoma. Hirabayashi Y; Ishida T; Yoshida MA; Kojima T; Ebihara Y; Machinami R; Ikeuchi T Cancer Genet Cytogenet; 1995 May; 81(1):33-7. PubMed ID: 7773957 [TBL] [Abstract][Full Text] [Related]
4. Extraskeletal myxoid chondrosarcoma with neuroendocrine differentiation: a case report with fine-needle aspiration biopsy, histopathology, electron microscopy, and cytogenetics. Domanski HA; Carlén B; Mertens F; Akerman M Ultrastruct Pathol; 2003; 27(5):363-8. PubMed ID: 14708728 [TBL] [Abstract][Full Text] [Related]
5. t(9;22)(q22-31;q11-12) is a consistent marker of extraskeletal myxoid chondrosarcoma: evaluation of three cases. Sciot R; Dal Cin P; Fletcher C; Samson I; Smith M; De Vos R; Van Damme B; Van den Berghe H Mod Pathol; 1995 Sep; 8(7):765-8. PubMed ID: 8539235 [TBL] [Abstract][Full Text] [Related]
6. Translocation t(9;22)(q22;q12) is a primary cytogenetic abnormality in extraskeletal myxoid chondrosarcoma. Stenman G; Andersson H; Mandahl N; Meis-Kindblom JM; Kindblom LG Int J Cancer; 1995 Aug; 62(4):398-402. PubMed ID: 7635565 [TBL] [Abstract][Full Text] [Related]
7. Recurrent breakpoints at 9q31 and 22q12.2 in extraskeletal myxoid chondrosarcoma. Turc-Carel C; Dal Cin P; Rao U; Karakousis C; Sandberg AA Cancer Genet Cytogenet; 1988 Jan; 30(1):145-50. PubMed ID: 3422040 [TBL] [Abstract][Full Text] [Related]
8. Skeletal and extraskeletal myxoid chondrosarcoma: a comparative clinicopathologic, ultrastructural, and molecular study. Antonescu CR; Argani P; Erlandson RA; Healey JH; Ladanyi M; Huvos AG Cancer; 1998 Oct; 83(8):1504-21. PubMed ID: 9781944 [TBL] [Abstract][Full Text] [Related]
9. Extraskeletal myxoid chondrosarcoma with neuroendocrine differentiation: a pathologic, cytogenetic, and molecular study of a case with a novel translocation t(9;17)(q22;q11.2). Harris M; Coyne J; Tariq M; Eyden BP; Atkinson M; Freemont AJ; Varley J; Attwooll C; Telford N Am J Surg Pathol; 2000 Jul; 24(7):1020-6. PubMed ID: 10895826 [TBL] [Abstract][Full Text] [Related]
10. Extraskeletal myxoid chondrosarcoma with a t(9;16)(q22;p11.2) resulting in a NR4A3-FUS fusion. Broehm CJ; Wu J; Gullapalli RR; Bocklage T Cancer Genet; 2014 Jun; 207(6):276-80. PubMed ID: 25130955 [TBL] [Abstract][Full Text] [Related]
11. Der(16)t(1;16)(q21;q13) as a secondary structural aberration in yet a third sarcoma, extraskeletal myxoid chondrosarcoma. Day SJ; Nelson M; Rosenthal H; Vergara GG; Bridge JA Genes Chromosomes Cancer; 1997 Dec; 20(4):425-7. PubMed ID: 9408761 [TBL] [Abstract][Full Text] [Related]
12. Fluorescence in situ hybridization is a useful ancillary diagnostic tool for extraskeletal myxoid chondrosarcoma. Wang WL; Mayordomo E; Czerniak BA; Abruzzo LV; Dal Cin P; Araujo DM; Lev DC; López-Terrada D; Lazar AJ Mod Pathol; 2008 Nov; 21(11):1303-10. PubMed ID: 18587326 [TBL] [Abstract][Full Text] [Related]
13. Poorly differentiated extraskeletal myxoid chondrosarcoma with t(9;22)(q22;q11) translocation presenting initially as a solid variant devoid of myxoid areas. Reid R; de Silva MV; Paterson L Int J Surg Pathol; 2003 Apr; 11(2):137-41. PubMed ID: 12754636 [TBL] [Abstract][Full Text] [Related]
14. Studies on the molecular pathogenesis of extraskeletal myxoid chondrosarcoma-cytogenetic, molecular genetic, and cDNA microarray analyses. Sjögren H; Meis-Kindblom JM; Orndal C; Bergh P; Ptaszynski K; Aman P; Kindblom LG; Stenman G Am J Pathol; 2003 Mar; 162(3):781-92. PubMed ID: 12598313 [TBL] [Abstract][Full Text] [Related]
15. Extraskeletal myxoid chondrosarcoma: updated clinicopathological and molecular genetic characteristics. Hisaoka M; Hashimoto H Pathol Int; 2005 Aug; 55(8):453-63. PubMed ID: 15998372 [TBL] [Abstract][Full Text] [Related]
16. Spectrum of cytomorphological features, including literature review, of an extraskeletal myxoid chondrosarcoma with t(9;22)(q22;q12) (TEC/EWS) results in one case. Kumar R; Rekhi B; Shirazi N; Pais A; Amare P; Gawde D; Jambhekar N Diagn Cytopathol; 2008 Dec; 36(12):868-75. PubMed ID: 18925568 [TBL] [Abstract][Full Text] [Related]
17. Extraskeletal myxoid chondrosarcoma: combining cytopathology with molecular testing to achieve diagnostic accuracy. Wakely PE J Am Soc Cytopathol; 2021; 10(3):293-299. PubMed ID: 32828707 [TBL] [Abstract][Full Text] [Related]
18. Molecular genetic characterization of the EWS/CHN and RBP56/CHN fusion genes in extraskeletal myxoid chondrosarcoma. Panagopoulos I; Mertens F; Isaksson M; Domanski HA; Brosjö O; Heim S; Bjerkehagen B; Sciot R; Dal Cin P; Fletcher JA; Fletcher CD; Mandahl N Genes Chromosomes Cancer; 2002 Dec; 35(4):340-52. PubMed ID: 12378528 [TBL] [Abstract][Full Text] [Related]
19. Myxoid chondrosarcoma (chordoid sarcoma) of bone: a report of two cases and review of the literature. Kilpatrick SE; Inwards CY; Fletcher CD; Smith MA; Gitelis S Cancer; 1997 May; 79(10):1903-10. PubMed ID: 9149016 [TBL] [Abstract][Full Text] [Related]
20. Cytopathology of extraskeletal myxoid chondrosarcoma: report of 8 cases. Jakowski JD; Wakely PE Cancer; 2007 Oct; 111(5):298-305. PubMed ID: 17676582 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]